Physician profile
Christopher Condorodis
NPI 1215163571
$3,251.30
in general payments reported to CMS, 2019-2025
36 companies · $421 in 2025
The $421 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $164 · 2021: $246 · 2022: $822 · 2023: $650 · 2024: $560 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,532 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.15 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $570.91 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $457.36 | 2019-2025 | Veozah |
| Abbvie INC. | $264.74 | 2020-2025 | Liletta, Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $193.54 | 2023-2025 | Myfembree, Gemtesa |
| Allergan, INC. | $143.26 | 2019-2020 | |
| Therapeuticsmd, INC. | $140.13 | 2019-2022 | |
| Exeltis, USA INC. | $140.02 | 2019-2023 | Slynd, Tyblume |
| Mayne Pharma Commercial LLC | $120.34 | 2022-2023 | |
| Shield Therapeutics INC | $113.99 | 2023-2024 | Accrufer |
| Optumhealth Care Solutions, LLC | $96.72 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Coopersurgical, INC. | $88.02 | 2023-2025 | Paragard T 380a, Advincula Delineator Uterine Manipulator, Paragard T 380a |
| Lupin INC. | $79.23 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $75.54 | 2019-2024 | Gardasil 9, Gardasil |
| Hologic Sales and Service, LLC | $75.26 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Amag Pharmaceuticals, INC. | $72.89 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $71.84 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.55 | 2022-2023 | |
| Millicent US INC | $52.31 | 2025 | Femlyv |
| Sage Therapeutics, LLC | $47.12 | 2023-2025 | Zurzuvae |
| Amgen INC. | $41.23 | 2021-2025 | Prolia, Evenity |
| Exact Sciences Corporation | $39.43 | 2025 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $37.11 | 2021-2023 | Twirla |
| Evofem Biosciences, INC. | $33.92 | 2021 | |
| Scynexis, INC. | $27.35 | 2022 | |
| Axonics, INC. | $26.89 | 2022 | |
| Boston Scientific Corporation | $25.80 | 2019 | |
| Myovant Sciences INC. | $25.54 | 2022 | |
| Meditrina | $22.81 | 2022 | |
| Daiichi Sankyo INC. | $19.76 | 2021 | |
| Olympus America INC. | $14.28 | 2019 | |
| Dexcom, INC. | $13.39 | 2023 | Dexcom G6 Transmitter |
| Avion Pharmaceuticals | $13.19 | 2023 | Balcoltra |
| Duchesnay USA Incorporated | $12.68 | 2019 | |
| Radius Health, INC. | $12.55 | 2019 | |
| Alfasigma USA, INC. | $12.46 | 2022 | |
| Minerva Surgical, INC | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Condorodis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.